Announcement on the Completion of Liquidation and Deregistration of Wholly-Owned Subsidiary by Jinling Pharmaceutical Co., Ltd.

✨ AI Summary

Jinling Pharmaceutical Co., Ltd. announced the completion of the liquidation and deregistration of its wholly-owned subsidiary, Huzhou Bangjian Tianfeng Pharmaceutical Co., Ltd. The decision was approved by the board on November 26, 2025. The subsidiary will no longer be included in the consolidated financial statements, and this action is not expected to adversely affect the company's overall business development or profitability.

Summary generated by AI · Always verify with source document